Name: Repare Therapeutics Inc. (RPTX) Balance Sheet
Creator: FinSpry

Repare Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Repare Therapeutics Inc. (RPTX) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	84.72	111.27	159.52	334.43	326.18
Short-Term Investments	68.07	112.36	184.42	7.44	7.53
Cash & Short-Term Investments	152.79	223.63	343.94	341.87	333.71
Accounts Receivable	12.35	15.31	4.32	3.23	6.16
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	6.01	4.75	5.72	6.31	6.68
Total Current Assets	171.15	243.69	353.98	351.41	346.55
Non-Current Assets
Property, Plant & Equipment (Net)	4.22	7.54	9.60	13.10	8.62
Other Non-Current Assets	1.14	2.67	0.50	0.59	0.50
Total Non-Current Assets	5.36	10.21	10.10	17.30	0.00
Total Assets	176.51	253.90	364.08	368.72	357.09
Current Liabilities
Accounts Payable	3.62	2.40	0.46	2.30	2.25
Short-Term Debt	1.85	0.00	0.00	0.00	0.00
Accrued Liabilities	19.65	23.86	15.76	16.53	5.79
Deferred Revenue	0.00	10.22	53.10	11.92	2.07
Other Current Liabilities	0.17	0.19	0.27	2.10	0.18
Total Current Liabilities	25.29	39.08	78.62	35.09	11.01
Non-Current Liabilities
Long-Term Debt	0.09	1.01	3.26	5.59	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	0.09	2.74	5.94	45.21	0.00
Total Liabilities	25.38	41.82	84.56	80.29	70.26
Stockholders' Equity
Common Stock	486.67	483.35	482.03	480.70	384.31
Retained Earnings	-417.80	-333.11	-239.31	-210.27	-103.36
Accumulated Other Comprehensive Income	0.06	0.03	-0.43	0.00	0.00
Additional Paid-in Capital	82.19	61.81	37.23	17.99	0.00
Shares Outstanding	42.51	42.18	42.04	41.85	0.00
Total Stockholders' Equity	151.13	212.08	279.52	288.42	286.83
Total Liabilities & Equity	176.51	253.90	364.08	368.72	0.00